Long-term comparative safety cohort studies of upadacitinib (Rinvoq™) use for the treatment of RA in Europe

12/02/2021
02/07/2024
EU PAS number:
EUPAS39217
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

p19150-protocol abstract-pmos_Redacted

English (218.99 KB - PDF) View document
Updated protocol

P19150-protocol-pmos-v3-Abstract_Redacted

First published: 22/02/2024
English (279.11 KB - PDF) View document
Study results
Study report
Other information